• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗真菌耐药时代的药房患者咨询。

Pharmacies Counselling of Patients in the Era of Antifungal Resistance.

机构信息

Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.

Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

出版信息

Mycoses. 2024 Sep;67(9):e13802. doi: 10.1111/myc.13802.

DOI:10.1111/myc.13802
PMID:39323058
Abstract

BACKGROUND

Tinea pedis is one of the most prevalent superficial fungal infections. Initial antifungal treatment is often acquired over-the-counter (OTC) without previous consultation with a physician.

OBJECTIVE

Lately, increasing antifungal terbinafine resistance has been documented in Denmark and globally and it is therefore of interest to assess how Danish pharmacies advise customers with tinea pedis.

METHODS

One hundred Danish pharmacies were randomly selected and an employee interviewed from each. A structured question guide was followed, with the possibility to add further comments.

RESULTS

Interviews of 94 pharmacies were conducted. Six pharmacies never replied. Terbinafine as standard dose or cutaneous solution terbinafine one time application (Lamisil Once (R)) were recommended by 99% of the pharmacy employees as first-line treatment. The customer was advised to seek medical attention when tinea pedis was recurring (93%), or when treatment duration was > 2 weeks (77%). The majority (88%) of the pharmacy employees had no knowledge about antifungal resistance.

CONCLUSION

Only few pharmacy employees were aware of the current problem of antifungal resistance and the majority advised costumers to initiate treatment using OTC topical terbinafine. The problem of emerging antifungal resistance requires attention in order to provide customers with tinea pedis effective treatment and prevent further societal spread of resistance to antifungals.

摘要

背景

足癣是最常见的浅部真菌感染之一。最初的抗真菌治疗通常是在没有事先咨询医生的情况下在药店购买非处方(OTC)药物进行的。

目的

最近,丹麦和全球范围内记录到抗真菌药物特比萘芬的耐药性不断增加,因此,评估丹麦的药店如何为患有足癣的患者提供建议是很有必要的。

方法

随机选择了 100 家丹麦药店,并对每家药店的一名员工进行了采访。采访遵循了一个结构化的问题指南,并允许添加进一步的评论。

结果

对 94 家药店进行了采访。有 6 家药店从未回复。99%的药店员工推荐标准剂量的特比萘芬或特比萘芬皮肤溶液(一次应用,兰美抒一次(R))作为一线治疗药物。当足癣复发(93%)或治疗持续时间超过 2 周(77%)时,建议顾客寻求医疗帮助。大多数(88%)的药店员工对抗真菌耐药性一无所知。

结论

只有少数药店员工意识到当前抗真菌耐药性的问题,并且大多数建议顾客使用 OTC 局部特比萘芬开始治疗。为了为患有足癣的患者提供有效的治疗,并防止抗真菌药物耐药性进一步在社会中传播,需要对抗真菌耐药性的出现问题引起关注。

相似文献

1
Pharmacies Counselling of Patients in the Era of Antifungal Resistance.抗真菌耐药时代的药房患者咨询。
Mycoses. 2024 Sep;67(9):e13802. doi: 10.1111/myc.13802.
2
Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.无论治疗方案如何,特比萘芬各种外用制剂治疗足癣的疗效和安全性相当:一项荟萃分析的结果
Am J Clin Dermatol. 2007;8(6):357-64. doi: 10.2165/00128071-200708060-00005.
3
Terbinafine-resistant tinea pedis and tinea unguium in Japanese military personnel.日本军事人员中对特比萘芬耐药的足癣和甲癣
J Dermatol. 2024 Sep;51(9):1256-1258. doi: 10.1111/1346-8138.17389. Epub 2024 Jul 15.
4
Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study.特比萘芬局部喷雾与特比萘芬局部溶液的疗效、耐受性和消费者可接受性:一项 IIa 期、随机、观察者盲、对照研究。
Am J Clin Dermatol. 2013 Oct;14(5):413-9. doi: 10.1007/s40257-013-0031-y.
5
Oral treatments for fungal infections of the skin of the foot.足部皮肤真菌感染的口服治疗方法。
Sao Paulo Med J. 2014;132(2):127. doi: 10.1590/1516-3180.20141322t1.
6
Results from a Phase 1/2 trial of BB2603, a terbinafine-based topical nano-formulation, in onychomycosis and tinea pedis.一项关于特比萘芬为基础的局部纳米制剂 BB2603 在甲真菌病和足癣中的 1/2 期临床试验结果。
Mycoses. 2022 Jun;65(6):661-669. doi: 10.1111/myc.13448. Epub 2022 May 20.
7
Consumer preferences of antifungal products for treatment and prevention of tinea pedis.消费者对治疗和预防足癣的抗真菌产品的偏好。
J Dermatolog Treat. 2019 Dec;30(8):745-749. doi: 10.1080/09546634.2019.1572862. Epub 2019 Jun 24.
8
Oral treatments for fungal infections of the skin of the foot.足部皮肤真菌感染的口服治疗方法。
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD003584. doi: 10.1002/14651858.CD003584.pub2.
9
[Topical terbinafine. Reduction of duration of therapy for tinea pedis].[外用特比萘芬。减少足癣治疗疗程]
Hautarzt. 2008 Dec;59(12):986-91. doi: 10.1007/s00105-008-1552-9.
10
Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.一种新型单剂量1%特比萘芬制剂治疗足癣(运动员脚癣)患者的疗效与安全性:一项随机、双盲、安慰剂对照研究。
J Eur Acad Dermatol Venereol. 2006 Nov;20(10):1307-13. doi: 10.1111/j.1468-3083.2006.01807.x.

引用本文的文献

1
Interdigital and Plantar Foot Infections: A Retrospective Analysis of Molecularly Diagnosed Specimens in the United States and a Literature Review.指间和足底足部感染:美国分子诊断标本的回顾性分析及文献综述
Microorganisms. 2025 Jan 16;13(1):184. doi: 10.3390/microorganisms13010184.